MetLife Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$530K Hold
23,093
﹤0.01% 1653
2025
Q1
$669K Sell
23,093
-359
-2% -$10.4K ﹤0.01% 1563
2024
Q4
$871K Buy
23,452
+845
+4% +$31.4K ﹤0.01% 1491
2024
Q3
$1.1M Hold
22,607
0.01% 1342
2024
Q2
$904K Buy
22,607
+3,090
+16% +$124K 0.01% 1394
2024
Q1
$857K Sell
19,517
-950
-5% -$41.7K 0.01% 1385
2023
Q4
$1.27M Hold
20,467
0.01% 1178
2023
Q3
$941K Hold
20,467
0.01% 1262
2023
Q2
$1.18M Hold
20,467
0.01% 1172
2023
Q1
$768K Hold
20,467
0.01% 1379
2022
Q4
$573K Hold
20,467
﹤0.01% 1555
2022
Q3
$575K Hold
20,467
﹤0.01% 1534
2022
Q2
$712K Hold
20,467
0.01% 1420
2022
Q1
$735K Buy
20,467
+8,664
+73% +$311K ﹤0.01% 1528
2021
Q4
$275K Hold
11,803
﹤0.01% 1855
2021
Q3
$224K Hold
11,803
﹤0.01% 2014
2021
Q2
$238K Hold
11,803
﹤0.01% 2043
2021
Q1
$216K Sell
11,803
-6,402
-35% -$117K ﹤0.01% 2014
2020
Q4
$366K Hold
18,205
﹤0.01% 1638
2020
Q3
$341K Hold
18,205
﹤0.01% 1564
2020
Q2
$409K Hold
18,205
﹤0.01% 1491
2020
Q1
$270K Hold
18,205
﹤0.01% 1534
2019
Q4
$351K Hold
18,205
﹤0.01% 1649
2019
Q3
$361K Hold
18,205
﹤0.01% 1591
2019
Q2
$384K Hold
18,205
﹤0.01% 1635
2019
Q1
$372K Hold
18,205
﹤0.01% 1630
2018
Q4
$362K Hold
18,205
﹤0.01% 1557
2018
Q3
$350K Hold
18,205
﹤0.01% 1757
2018
Q2
$278K Hold
18,205
﹤0.01% 1749
2018
Q1
$341K Hold
18,205
﹤0.01% 1610
2017
Q4
$350K Buy
+18,205
New +$350K ﹤0.01% 1618